Check Point Benefits From Software Blade Growth and 3 Must-See Stock Analyses
Check Point Software Technologies Ltd. (NASDAQ:CHKP): Credit Suisse stated that Check Point is still benefiting from software blade growth and high unit growth levels, but trading to new lower priced appliances pressures ASPs lower. According to the firm, September guidance is able to be reached, and the firm believes that there will be a re-acceleration in product revenue growth during the March quarter. The firm still views Check Point as a compelling investment, and it keeps its Outperform rating and a $67 price target on the stock.
FedEx Corporation (NYSE:FDX) target has been raised by Stifel Nicolaus following the company’s announcement of an “annual profit improvement target” of $1.7 billion by FY16. Now, the firm has become more upbeat on the stock because of the size of the company’s margin expansion opportunities, and it believes that this margin expansion is possible. The firm keeps its Buy rating on the stock.
Are these stocks a buy or sell? Let us help you decide. Check out our Wall St. Cheat Sheet Stock Picker Newsletter now >>
Google Inc. (NASDAQ:GOOG) price target has been increased by Susquehanna due to a rebound in strong keyword pricing and solid growth in cost per click rates. Shares keep a Positive rating.
Valeant Pharmaceuticals International (NYSE:VRX): According to Stifel Nicolaus, Valeant’s stock currently does not reflect the accretive potential of Medicis (NYSE:MRX), which will be acquire by Valean. The firm believes that Medicis has the ability to add $1.50 to Valeant’s EPS by 2016, and it maintains its Buy rating on the stock.
Don’t Miss: Is This Drug Giant’s Stock a Buy Now?